Back
Taysha Gene Therapies, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
64
TSHA
Taysha Gene Therapies, Inc.
Last Price:
$5.05
Seasonality Move:
-10.93%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTaysha Gene Therapies, Inc. Stock Forecast
-
Over the next 52 weeks, Taysha Gene Therapies, Inc. has on average historically fallen by 6.5% based on the past 5 years of stock performance.
-
Taysha Gene Therapies, Inc. has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Taysha Gene Therapies, Inc. Stock Undervalued?The current Taysha Gene Therapies, Inc. [TSHA] share price is $5.05. The Score for TSHA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
TSHA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Taysha Gene Therapies, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Taysha Gene Therapies, Inc. has on average historically fallen by 6.5% based on the past 5 years of stock performance.
Taysha Gene Therapies, Inc. Stock Rating
Buy
64
Taysha Gene Therapies, Inc. (TSHA)
is a Buy
Is Taysha Gene Therapies, Inc. overpriced?
-
Taysha Gene Therapies, Inc. has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Taysha Gene Therapies, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tayshagtx.com
52-Week Data
52-Week High:
5.51
52-Week Low:
1.05
Prediction Charts
Market Cap:
1.4B
Price in USD:
5.05
Volume:
3M
Beta:
1.03
Technical Analysis
SMA50:
4.49
SMA100:
3.69
SMA200:
2.88
52-Wk Change:
112.18%
Stock Predictions
-
Is Taysha Gene Therapies, Inc. stock public?Yes, Taysha Gene Therapies, Inc. is a publicly traded company.
-
What is the Taysha Gene Therapies, Inc. stock quote today?The Taysha Gene Therapies, Inc. stock price is 5.05 USD today.
-
How to buy Taysha Gene Therapies, Inc. stock online?You can buy Taysha Gene Therapies, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 4.10 | 4.12 | 4.26 | 4.05 |
| Nov-18 | 4.12 | 4.15 | 4.34 | 4.05 |
| Nov-19 | 4.17 | 4.01 | 4.21 | 4.00 |
| Nov-20 | 4.16 | 3.99 | 4.22 | 3.92 |
| Nov-21 | 3.99 | 4.19 | 4.34 | 3.97 |
| Nov-24 | 4.23 | 4.42 | 4.44 | 4.23 |
| Nov-25 | 4.44 | 4.59 | 4.60 | 4.34 |
| Nov-26 | 4.64 | 4.86 | 4.89 | 4.61 |
| Nov-28 | 4.90 | 4.74 | 4.92 | 4.72 |
| Dec-1 | 4.61 | 4.43 | 4.64 | 4.42 |
| Dec-2 | 4.44 | 4.06 | 4.47 | 4.03 |
| Dec-3 | 4.10 | 4.49 | 4.52 | 4.10 |
| Dec-4 | 4.82 | 5.06 | 5.10 | 4.65 |
| Dec-5 | 5.13 | 5.05 | 5.24 | 5.01 |
Taysha Gene Therapies, Inc. Earnings
Taysha Gene Therapies, Inc. Earnings Report: Per Share Taysha Gene Therapies, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Taysha Gene Therapies, Inc. Forecast Revenue Growth
Taysha Gene Therapies, Inc. Stock Analysis: Historical quarterly revenues per share for Taysha Gene Therapies, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.10 per share.
* Taysha Gene Therapies, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.